NLRC3

NLR family CARD domain containing 3, the group of NLR family

Basic information

Region (hg38): 16:3539033-3577403

Links

ENSG00000167984NCBI:197358OMIM:615648HGNC:29889Uniprot:Q7RTR2AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the NLRC3 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the NLRC3 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
3
clinvar
1
clinvar
4
missense
94
clinvar
12
clinvar
3
clinvar
109
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
1
1
non coding
0
Total 0 0 94 15 4

Variants in NLRC3

This is a list of pathogenic ClinVar variants found in the NLRC3 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
16-3541823-G-A not provided (-)103374
16-3541886-C-T not specified Uncertain significance (Feb 03, 2022)2379430
16-3542215-C-T not specified Uncertain significance (Dec 09, 2024)3406021
16-3542959-C-A not provided (-)102958
16-3543426-C-T not provided (-)102959
16-3544289-C-T not specified Uncertain significance (Feb 07, 2025)2267133
16-3544314-G-A not provided (-)103373
16-3544380-T-C not provided (-)132884
16-3548149-G-A not provided (-)103371
16-3548189-G-A not provided (-)103372
16-3548190-C-T Likely benign (Feb 01, 2025)2646106
16-3548584-G-C not provided (-)102960
16-3548727-T-G not provided (-)102961
16-3549162-G-C not provided (-)102962
16-3549219-T-C not provided (-)103370
16-3550427-G-C not specified Uncertain significance (Feb 14, 2023)2483789
16-3552260-C-T not specified Uncertain significance (Dec 15, 2022)2283150
16-3554270-C-T not specified Uncertain significance (Oct 29, 2024)3406023
16-3554279-C-T not specified Uncertain significance (Jun 17, 2024)2395819
16-3554290-C-G not specified Uncertain significance (Nov 12, 2021)2358303
16-3554318-C-T not specified Likely benign (Feb 13, 2023)2483042
16-3554573-A-C not provided (-)103368
16-3554618-C-G not provided (-)103369
16-3556537-C-G not provided (-)103367
16-3556662-G-A not provided (-)103366

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
NLRC3polymorphic_pseudogeneprotein_codingENST00000448023 1938369
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
2.23e-250.00074912441122381246510.000963
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.4947056691.050.00004257053
Missense in Polyphen137130.911.04651573
Synonymous-1.243393111.090.00002212351
Loss of Function0.2883941.00.9510.00000190470

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.003790.00378
Ashkenazi Jewish0.00009970.0000994
East Asian0.0004730.000445
Finnish0.0004320.000418
European (Non-Finnish)0.0005670.000549
Middle Eastern0.0004730.000445
South Asian0.001210.00114
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Negative regulator of the innate immune response (PubMed:15705585, PubMed:22863753, PubMed:25277106). Attenuates signaling pathways activated by Toll-like receptors (TLRs) and the DNA sensor STING/TMEM173 in response to pathogen-associated molecular patterns, such as intracellular poly(dA:dT), but not poly(I:C), or in response to DNA virus infection, including that of Herpes simplex virus 1 (HSV1) (By similarity) (PubMed:22863753). May affect TLR4 signaling by acting at the level of TRAF6 ubiquitination, decreasing the activating 'Lys-63'- linked ubiquitination and leaving unchanged the degradative 'Lys- 48'-linked ubiquitination (PubMed:22863753). Inhibits the PI3K- AKT-mTOR pathway possibly by directly interacting with the posphatidylinositol 3-kinase regulatory subunit p85 (PIK3R1/PIK3R2) and disrupting the association between PIK3R1/PIK3R2 and the catalytic subunit p110 (PIK3CA/PIK3CB/PIK3CD) and reducing PIK3R1/PIK3R2 activation. Via its regulation of the PI3K-AKT-mTOR pathway, controls cell proliferation, predominantly in intestinal epithelial cells (By similarity). May also affect NOD1- or NOD2-mediated NF-kappa-B activation (PubMed:25277106). Might also affect the inflammatory response by preventing NLRP3 inflammasome formation, CASP1 cleavage and IL1B maturation (PubMed:25277106). {ECO:0000250|UniProtKB:Q5DU56, ECO:0000269|PubMed:15705585, ECO:0000269|PubMed:22863753, ECO:0000269|PubMed:25277106}.;
Pathway
STING mediated induction of host immune responses;Innate Immune System;Immune System;IRF3-mediated induction of type I IFN;Cytosolic sensors of pathogen-associated DNA (Consensus)

Recessive Scores

pRec
0.112

Haploinsufficiency Scores

pHI
0.145
hipred
N
hipred_score
0.251
ghis

Essentials

essential_gene_CRISPR
essential_gene_CRISPR2
N
essential_gene_gene_trap
gene_indispensability_pred
gene_indispensability_score

Mouse Genome Informatics

Gene name
Nlrc3
Phenotype
hematopoietic system phenotype; immune system phenotype; growth/size/body region phenotype; homeostasis/metabolism phenotype;

Gene ontology

Biological process
I-kappaB kinase/NF-kappaB signaling;negative regulation of phosphatidylinositol 3-kinase signaling;negative regulation of NF-kappaB transcription factor activity;negative regulation of interferon-alpha production;negative regulation of interferon-beta production;negative regulation of interleukin-6 production;negative regulation of tumor necrosis factor production;intracellular signal transduction;T cell activation;negative regulation of I-kappaB kinase/NF-kappaB signaling;negative regulation of innate immune response;negative regulation of fibroblast proliferation;negative regulation of epithelial cell proliferation;negative regulation of inflammatory response;negative regulation of cytokine production involved in inflammatory response;negative regulation of NLRP3 inflammasome complex assembly;negative regulation of NIK/NF-kappaB signaling
Cellular component
cytoplasm;microtubule organizing center;cytosol;perinuclear region of cytoplasm
Molecular function
molecular_function;protein binding;ATP binding;phosphatidylinositol 3-kinase regulatory subunit binding